The global surgical robotics market is expanding rapidly and may soon be worth $120B. But is the medical training ecosystem ready for the shift to robot-assisted surgeries? As more surgeons use robots in the OR, the approach for training on them and using them needs to be standardized. The truth is that all surgeons aren't approaching this innovative tech the same way. Standardized best practices are what set surgeons and patients up for success, and will help to make robotic surgery safer in the future.
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence (AI) in Operating Room Market: Focus on Offering, Technology, Indication, Application, End User, Unmet Demand, Cost-Benefit Analysis, and Over 16 Countries' Data - Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering. The purpose of the study is to enable the reader to gain a holistic view of the global AI in the operating room market by each of the aforementioned segments. The report constitutes an in-depth analysis of the global AI in the operating room market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers software solutions and hardware solutions integrated with AI. "I think these are exciting times. Not considering the buzz around AI, ultimately, it is an enabler to do things at scale and quickly. It needs to serve a higher purpose that provides surgeons or other stakeholders in the healthcare ecosystem with value. The real value that a company provides with AI is the key component. This technology can be leveraged to tackle the disparity in the world of surgery".
Every Robotic Assisted Surgeries (RAS) requires some level of navigation. While in open surgery the target is viewed directly, minimally invasive RAS views come from inside the body cavity, with a restricted field-of-view (FOV). Also, the surgeon's hands are occupied with the tools, whereas the camera is controlled by an assistant, adding another complication to the procedure – requiring perfect collaboration between them. Another challenge arises from anatomical and physiological differences between patients which make it difficult to accurately position surgical tools and recognize target organs. In gastroscopies or colonoscopies, the singular wide-angle view is often difficult to interpret, and objective navigational aid can be beneficial.
Raipur: The All India Institute of Medical Sciences Raipur in Chhattisgarh organized a ''Continuing Medical Education'' (CME) seminar on Artificial Intelligence in healthcare, with 625 delegates taking part, officials said on Sunday. The aim was to find out how AI-based technology could be accommodated in diagnostics and patient management while taking care of accountability, transparency and privacy issues. AIIMS Raipur president Professor George A D''Souza said AI was being used in diagnostics, surgery, patient management, drug discovery and administration as well as fields like dermatology, ophthalmology and radiology. "We have to address several issues and safeguard the interests of different stakeholders while using AI in healthcare. These include privacy, consent of the patient, interpretation of data, accountability and transparency," he said.
Applicable only in its native Sweden, the firm's patent covers the uploading of a patient's 3D scan to an autonomous system, which uses this data to perform cosmetic filler procedures via bioprinting-armed robotics. Given that it's invention potentially provides patients with faster and more accurate plastic surgeries, CELLINK says that with further tweaking, it could find commercial applications moving forwards. "This invention shows our innovative research & development capabilities and passion for improving patient's outcomes, whether for cosmetic or reconstructive surgery," said Dr. Héctor Martínez, CTO of CELLINK. "This granted patent can potentially offer commercial opportunities for the CELLINK Group." "We foresee that this robotic system enables cutting-edge possibilities to deliver personalized aesthetic outcomes and we will continue to explore it."
Guy's and St Thomas' NHS Foundation Trust has added a fourth surgical robot to to its collection in a bid to speed up cancer operations delayed by the pandemic. The new addition joins three 4th generation da Vinci surgical systems from manufacturer Intuitive which the trust already owns and with four machines, the trust now has the largest robotic programme in the UK currently. The new robot, which is on loan until the end of the year, will operate on NHS patients from the private floors of the Cancer Centre at Guy's as part of a collaboration with private healthcare provider, HCA Healthcare UK. The new delivery will help to clear a backlog of surgical procedures and it is also hoped it will lead to improved patient outcomes. The use of robots in surgery leads to increased operative precision which can mean less pain for patients, smaller scars and reduced hospital stays post-surgery.
Dr. Stephen Murphy had conducted countless hip replacement operations before, but this one was different. In this one, he and his team could see a 3D hologram overlaid on the patient -- a digital model of the patient's body that existed directly in his line of vision. The surgical team had a form of X-ray vision with augmented reality. "We had done a lot of testing on real human specimens, so we knew what it was going to look like, but to see it in a live patient for the first time was just unbelievable," Murphy said in an interview with Freethink. "It feels to the surgeon as if she has been transported inside of the patient."
There are no clear advantages to using robots during surgery, according to researchers from the University of Texas. In a study, the researchers reviewed 50 published randomised controlled trials comprising more than 4,800 patients to assess the quality of evidence and outcomes for robot-assisted open surgery compared with laparoscopy, open surgery, or both. From reviewing those studies, the researchers found a majority of the findings demonstrated there were no clear advantages gained from performing robot-assisted surgeries when looking at intraoperative complications, conversion rates to open surgery, and long-term outcomes despite robot-assisted surgeries often coming with "extreme costs". The initial cost of the most prevalent robotic platform is $1.5 million, the researchers said, which does not account for additional costs such as upkeep or training people to use the robots. In addition to the big cost, the researchers said robot-assisted surgeries usually took longer to complete despite there being no obvious differences in the results compared with standard surgeries.